4//SEC Filing
Sun BioPharma, Inc. 4
Accession 0001437749-17-005021
CIK 0001029125operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 5:13 PM ET
Size
5.7 KB
Accession
0001437749-17-005021
Insider Transaction Report
Form 4
KAYSEN DAVID B
President and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2017-03-17+248,000→ 424,000 totalExercise: $1.51Exp: 2026-12-12→ Common Stock (248,000 underlying)
Footnotes (2)
- [F1]On December 12, 2016, the reporting person was granted an option to purchase up to 800,000 shares of common stock. The option became exercisable with respect to 176,000 shares as of December 12, 2016 and with respect to an additional 248,000 shares as of March 17, 2017. The remainder is subject to vesting proportionately based on cash proceeds received by, or contractually obligated to be remitted to, the issuer after June 1, 2016 and before December 31, 2018 from any transaction, excluding certain internal operating-related cash flows.
- [F2]Option vested with respect to 248,000 additional shares pursuant to certification by issuer compensation committee.
Documents
Issuer
Sun BioPharma, Inc.
CIK 0001029125
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001029125
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 5:13 PM ET
- Size
- 5.7 KB